FINWIRES · TerminalLIVE
FINWIRES

CIBCによると、金と石油の輸出急増により、カナダの貿易収支は3月に「予想外に」黒字に転じた。

By

-- CIBCは火曜日に発表された商品貿易統計を受け、金と原油の輸出が価格上昇に牽引されて急増し、カナダの3月の貿易収支は「予想外に」黒字に転じたと発表した。 同行によると、18億ドルの商品貿易黒字は、前月の51億ドルの赤字、そして市場予想の25億ドルの赤字を大きく上回るものだった。 輸出総額は前月比8.5%増と急増し、その増加はほぼ金属とエネルギーによるものだった。これら2品目を除くと、輸出は1.1%増と、はるかに小幅な伸びにとどまった。 CIBCは、名目輸出の急増は主に価格上昇によるものであり、数量ベースでは輸出総額はそれほど伸びていないと指摘した。 輸出の好調とは対照的に、輸入は消費財を中心に前月比で減少した。 同行によると、「火曜日に発表されたデータは、世界的なエネルギー価格の上昇がカナダの名目貿易収支の改善に貢献していることを概ね裏付けているが、経済活動の規模拡大にはまだ大きな改善をもたらしていない」とのことだ。

Related Articles

Australia

Citigroup Adjusts Price Target on Marathon Petroleum to $257 From $243, Maintains Neutral Rating

Marathon Petroleum (MPC) has an average rating of overweight and mean price target of $253.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $256.58, Change: $+4.04, Percent Change: +1.60%

$MPC
Research

Research Alert: Peg Reports Strong Q1 Beat; On Track For $4.2b Capex And 7% Eps Growth In 2026

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:PEG reported Q1 2026 adjusted EPS of $1.55 vs. $1.43 (+8.4% Y/Y, +8.5% vs. consensus), supported by higher PSE&G margins from regulated infrastructure investments and customer growth, partially offset by higher depreciation and interest expense. PSEG Power earnings increased due to higher realized power prices and lower O&M costs, offset by lower generation volumes. We see the company as on target for $4.2B full-year 2026 capex guidance after deploying ~$0.8B in Q1, while PEG maintained long-term targets including $24B-$28B total capex for 2026-2030 and a 6%-7.5% rate base CAGR. Management reaffirmed its 2026 EPS guidance of $4.28-$4.40, representing ~7% growth at the midpoint. Both residential electric and gas customers increased ~1% on a trailing-12-month basis, which we think reflects continued execution of the regulated investment program. Annualized dividends were increased ~6% to $2.68 for 2026. We view this as a competitive growth rate amongst Multi-Utility peers.

$PEG
Australia

Merck Completes Terns Pharmaceuticals Acquisition

Merck (MRK) said Tuesday it has completed the acquisition of Terns Pharmaceuticals after a cash tender offer at $53 per share.Terns' stock will no longer be listed on Nasdaq, it said.The deal will result in a charge to research and development expense of about $2.35 per share, included in Q2 and full year 2026 GAAP and non-GAAP results, Merck said.GAAP and non-GAAP EPS are also expected to take a hit of about $0.12 a share in 2026 on costs associated with advancing TERN-701 and costs of financing, it added.Price: $113.21, Change: $+0.10, Percent Change: +0.09%

$MRK$TERN